Viewing StudyNCT00083941



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00083941
Status: COMPLETED
Last Update Posted: 2020-10-19
First Post: 2004-06-03

Brief Title: A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer
Sponsor: Oxford BioMedica
Organization: Oxford BioMedica

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-08
Start Date Type: None
Primary Completion Date: 2008-07
Primary Completion Date Type: ACTUAL
Completion Date: 2008-07
Completion Date Type: ACTUAL
First Submit Date: 2004-06-03
First Submit QC Date: June 4 2004
Study First Post Date: 2004-06-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2020-09-29
Disp First Submit QC Date: September 29 2020
Disp First Post Date: 2020-10-08
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2020-10-08
Last Update Post Date: 2020-10-19
Last Update Post Date Type: ACTUAL